These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3033177

  • 1. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [Abstract] [Full Text] [Related]

  • 2. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S, Rennke HG, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [Abstract] [Full Text] [Related]

  • 3. The role of intraglomerular pressure in the initiation and progression of renal disease.
    Anderson S, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S, Brenner BM.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [Abstract] [Full Text] [Related]

  • 5. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
    Windt WA, Tahara A, Kluppel AC, de Zeeuw D, Henning RH, van Dokkum RP.
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Dec; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 7. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Dec; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 8. Reversing glomerular hypertension stabilizes established glomerular injury.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    Kidney Int; 1987 Mar; 31(3):752-9. PubMed ID: 3033388
    [Abstract] [Full Text] [Related]

  • 9. [The effect of a low-protein diet and certain pharmaceutical agents on the course of ablation nephropathy in rats].
    Heller J, Cervenka L, Hellerová S.
    Cas Lek Cesk; 1994 Jul 18; 133(14):429-33. PubMed ID: 8069900
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Jul 18; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 11. Prevention of glomerular capillary hypertension in experimental diabetes mellitus obviates functional and structural glomerular injury.
    Dunn BR, Zatz R, Rennke HG, Meyer TW, Anderson S, Brenner BM.
    J Hypertens Suppl; 1986 Dec 18; 4(5):S251-4. PubMed ID: 3033178
    [Abstract] [Full Text] [Related]

  • 12. Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats.
    Lee SK, Jin SY, Han DC, Hwang SD, Lee HB.
    Nephrol Dial Transplant; 1993 Dec 18; 8(12):1338-43. PubMed ID: 8159302
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S, Rennke HG, Brenner BM.
    J Clin Invest; 1986 Jun 18; 77(6):1993-2000. PubMed ID: 3011863
    [Abstract] [Full Text] [Related]

  • 14. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD.
    Kidney Int; 1993 Apr 18; 43(4):808-14. PubMed ID: 8479116
    [Abstract] [Full Text] [Related]

  • 15. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Apr 18; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 16. Renal functional reserve in experimental chronic glomerulonephritis.
    De Nicola L, Peterson OW, Obagi S, Kaiser JA, Wilson CB, Gabbai FB.
    Nephrol Dial Transplant; 1994 Apr 18; 9(10):1383-9. PubMed ID: 7816249
    [Abstract] [Full Text] [Related]

  • 17. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy.
    Adams LG, Polzin DJ, Osborne CA, O'Brien TD, Hostetter TH.
    Lab Invest; 1994 Mar 18; 70(3):347-57. PubMed ID: 8145529
    [Abstract] [Full Text] [Related]

  • 18. Effects of dietary protein and captopril on glomerular permselectivity in rats with unilateral nephrectomy.
    Cartwright ME, Jaenke RS.
    Lab Invest; 1988 Oct 18; 59(4):492-9. PubMed ID: 2459500
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive agents and renal protection: calcium channel blockers.
    Saruta T, Kanno Y, Hayashi K, Konishi K.
    Kidney Int Suppl; 1996 Jun 18; 55():S52-6. PubMed ID: 8743511
    [Abstract] [Full Text] [Related]

  • 20. Acute and long-term effects of ACE inhibition on renal haemodynamics in glomerular and interstitial nephropathies.
    Guidi E, Minetti EE, Cozzi MG.
    J Renin Angiotensin Aldosterone Syst; 2002 Mar 18; 3(1):40-5. PubMed ID: 11984747
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.